Claritev Corporation

Worth knowing

• Negative shareholders' equity. Liabilities exceed assets on the balance sheet.

  Claritev's liabilities exceed its assets on the balance sheet. Large share buybacks can cause this in healthy companies, but so can accumulated losses; either way, debt-based ratios need care.

• Stock pay outran buybacks. Stock-based pay expense $72M vs $26M spent repurchasing shares over the 3 fiscal years to 2025.

  Over three fiscal years Claritev recorded $72M of stock-based pay expense and spent $26M repurchasing shares (repurchases can include shares withheld to cover employees' taxes). Repurchases were smaller than the stock pay, so they did little to offset new employee shares.Over three fiscal years Claritev recorded $72M of stock-based pay expense and spent $26M repurchasing shares. Repurchases were smaller than the stock pay, so they did little to offset new employee shares.

• Investment surge. Capital spending 13% of revenue, up from 8.3% in 2022.

  Claritev is spending 13% of revenue on facilities and equipment, up from 8.3% in 2022. That weighs on free cash flow today; whether it pays off depends on the returns those investments earn.

• Valuation signals disagree. Cheaper than 80% of peers on operating cash profit (EBITDA), but only 0% on earnings.Cheaper than 80% of peers on operating cash profit, but only 0% on earnings.

  Relative to its operating cash profit (EBITDA), Claritev looks cheaper than 80% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.Relative to its operating cash profit, Claritev looks cheaper than 80% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.